Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBLG | AMGN | VRTX | REGN | BMY |
| Company | Bone Biologics Corp | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 1.5800 | 274.18 | 392.81 | 889.41 | 43.97 |
| High | 1.6500 | 275.98 | 396.12 | 895.66 | 44.47 |
| Low | 1.5500 | 273.38 | 392.47 | 888.52 | 43.73 |
| Last | 1.5500 | 276.58 | 395.56 | 897.78 | 44.27 |
| Change | -0.0115 | +2.64 | +2.75 | +7.12 | +0.33 |
| % Change | -0.74% | +0.96% | +0.70% | +0.80% | +0.75% |
| Volume | 2,597 | 281,555 | 122,753 | 51,168 | 3,448,731 |
| 20-Day Average Volume | 36,800 | 2,138,073 | 941,608 | 448,432 | 13,537,995 |
| Previous Close | 1.5615 | 273.94 | 392.81 | 890.66 | 43.94 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.6487 | 269.53 | 398.50 | 908.50 | 48.20 |
| 20-Day Raw Stochastic | 15.25% | 84.24% | 14.56% | 18.08% | 3.49% |
| 20-Day Relative Strength | 36.19% | 49.96% | 40.67% | 37.10% | 27.53% |
| Weighted Alpha | -87.51 | +12.82 | +11.63 | +14.93 | -36.61 |
| Today's Opinion | 100% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Previous Opinion | 100% Sell | 40% Sell | 24% Sell | 8% Buy | 88% Sell |
| Last Month's Opinion | 100% Sell | 8% Sell | 40% Buy | 64% Buy | 8% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.63% since 04/24/24 | +0.48% since 04/24/24 | -1.65% since 04/24/24 | -1.72% since 04/24/24 | -9.91% since 04/24/24 |
| Low | 1.4701 on 04/25/24 | 265.72 on 04/26/24 | 391.70 on 04/30/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 1.6500 on 05/01/24 | 276.86 on 04/29/24 | 403.88 on 04/25/24 | 915.00 on 04/25/24 | 47.50 on 04/25/24 |
| 1-Month | |||||
| %Chg | -27.23% since 04/01/24 | -3.08% since 04/01/24 | -6.26% since 04/01/24 | -8.08% since 04/01/24 | -16.93% since 04/01/24 |
| Low | 1.4600 on 04/24/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 2.2800 on 04/02/24 | 283.91 on 04/02/24 | 420.87 on 04/02/24 | 962.20 on 04/04/24 | 53.35 on 04/02/24 |
| 3-Month | |||||
| %Chg | -53.59% since 02/01/24 | -15.48% since 02/01/24 | -9.15% since 02/01/24 | -6.98% since 02/01/24 | -9.55% since 02/01/24 |
| Low | 1.4600 on 04/24/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 43.73 on 05/01/24 |
| High | 4.7400 on 02/09/24 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| 6-Month | |||||
| %Chg | -63.44% since 11/01/23 | +5.16% since 11/01/23 | +6.72% since 11/01/23 | +12.60% since 11/01/23 | -14.16% since 11/01/23 |
| Low | 1.4600 on 04/24/24 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 783.57 on 11/10/23 | 43.73 on 05/01/24 |
| High | 10.5600 on 12/28/23 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 998.33 on 02/28/24 | 55.03 on 03/13/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 834 | 146,934,848 | 101,525,288 | 97,760,624 | 89,070,768 |
| Shares Outstanding, K | 534 | 536,376 | 258,459 | 109,762 | 2,027,100 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 45,006,000,000 |
| Annual Net Income | -8,950,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 8,025,000,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 2,517,700,000 | 3,434,300,000 | 11,865,000,000 |
| Last Quarter Net Income | -1,550,000 | 767,000,000 | 968,800,000 | 1,159,600,000 | -11,911,000,000 |
| 60-Month Beta | 0.18 | 0.58 | 0.35 | 0.11 | 0.39 |
| Per-Share Information | |||||
| Most Recent Earnings | -4.88 on 11/14/23 | 4.71 on 02/06/24 | 4.20 on 02/05/24 | 11.86 on 02/02/24 | -4.40 on 04/25/24 |
| Latest Earnings Date | 05/20/24 | 05/02/24 | 05/06/24 | 05/02/24 | 04/25/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | N/A | 0.600 on 04/04/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 04/04/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.82 | 29.48 | 23.75 | 42.51 |